EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Accumulation of ether phospholipids in induced pluripotent stem cells and oligodendrocyte‐lineage cells established from patients with Sjögren‐Larsson syndrome

Yu Yamaguchi, Hironobu Okuno iD, Suzumi Tokuoka, Yoshihiro Kita, Tsukasa Sanosaka, Jun Kohyama, Kenji Kurosawa iD, Norio Sakai, Fuyuki Miya, Takao Takahashi, Kenjiro Kosaki, Hideyuki Okano

Congenital Anomalies · 2025

DOI: 10.1111/cga.12587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Congenital Anomalies, 2025. Verfasst von Yu Yamaguchi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Gunma Children's Medical Center, Shibukawa, Japan. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Sjogren-Larsson Syndrome, Oligodendroglia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Agency for Medical Reseach and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sjögren‐Larsson syndrome (SLS) is an autosomal recessive leukodystrophy characterized by ichthyosis, intellectual disability, and progressive spastic paralysis caused by biallelic pathogenic variants in the ALDH3A2 gene that encodes the fatty aldehyde dehydrogenase, fatty aldehyde dehydrogenase (FALDH); FALDH catalyzes several metabolic reactions involved in fatty aldehyde oxidation. Only a few studies have been performed to determine the lipid profile of patients with SLS. In a previous postmortem study of the brain of a 65‐year‐old patient with SLS, lipidomic analysis revealed an accumulation of long‐chain unsaturated ether lipid species in the white matter and gray matter. In the present study, we established a disease model using patient‐derived neuronal and oligodendrocyte lineage cells to analyze the lipid metabolism and gene expression profiles in SLS. To achieve this, we generated induced pluripotent stem cells (iPSCs) from two patients with the SLS phenotype carrying previously known ALDH3A2 pathogenic variants: One was a compound heterozygote (c.1339A>G:p.(Lys447Glu) and c.57_132dup:p.(Ile45Serfs*34)) and the other was a homozygote (c.1339A>G: p.(Lys447Glu)). The FALDH activity was almost zero in the SLS‐iPSC lines established from both patients. Phospholipid analysis of neurospheres, and oligospheres (spheres enriched with oligodendrocyte‐lineage cells) derived from the iPSCs by liquid chromatography‐mass spectrometry showed accumulation of ether phospholipids in the Sjögren‐Larsson patient‐derived neurospheres and oligospheres. The results are consistent with the previously reported accumulation of ether lipids in the postmortem brain tissue of an SLS patient. Therefore, iPSCs and iPSC‐derived neurospheres and oligospheres established from SLS patients can be useful tools for future pathological analysis of the central nervous system pathophysiology in SLS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsSjogren-Larsson SyndromeOligodendrogliaHumansPhospholipid EthersCell LineageAldehyde OxidoreductasesFemaleMaleCell DifferentiationMutation

Stichwörter der Autor:innen

FALDHSjögren‐Larsson syndromeether phospholipidinduced pluripotent stem cellsoligodendrocytes

Substanzen

long-chain-aldehyde dehydrogenasePhospholipid EthersAldehyde Oxidoreductases

Autor:innen und Institutionen

  • Department of Genetics, Gunma Children's Medical Center, Shibukawa, Japan.
  • Department of Physiology, Keio University School of Medicine, Tokyo, Japan.
  • Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
  • Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan.
  • Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.
  • Department of Lipidomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Hironobu Okuno, Kenji Kurosawa

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Agency for Medical Reseach and Development

Zitieren

APA

Yamaguchi, Y., Okuno, H., Tokuoka, S., Kita, Y., Sanosaka, T., Kohyama, J., Kurosawa, K., Sakai, N., Miya, F., Takahashi, T., Kosaki, K., & Okano, H. (2025). Accumulation of ether phospholipids in induced pluripotent stem cells and oligodendrocyte‐lineage cells established from patients with Sjögren‐Larsson syndrome. Congenital Anomalies. https://doi.org/10.1111/cga.12587

Vancouver

Yamaguchi Y, Okuno H, Tokuoka S, Kita Y, Sanosaka T, Kohyama J, et al. Accumulation of ether phospholipids in induced pluripotent stem cells and oligodendrocyte‐lineage cells established from patients with Sjögren‐Larsson syndrome. Congenital Anomalies. 2025. doi:10.1111/cga.12587

BibTeX
@article{Yamaguchi2025,
  author = {Yamaguchi, Yu and Okuno, Hironobu and Tokuoka, Suzumi and Kita, Yoshihiro and Sanosaka, Tsukasa and Kohyama, Jun and Kurosawa, Kenji and Sakai, Norio and Miya, Fuyuki and Takahashi, Takao and Kosaki, Kenjiro and Okano, Hideyuki},
  title = {Accumulation of ether phospholipids in induced pluripotent stem cells and oligodendrocyte‐lineage cells established from patients with Sjögren‐Larsson syndrome},
  journal = {Congenital Anomalies},
  year = {2025},
  doi = {10.1111/cga.12587}
}
Kostenlos starten →